{"id":"W2697574135","doi":"10.1111/bjd.15750","title":"Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase <scp>III NAVIGATE</scp> trial","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":339,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"Janssen Research and Development","keywords":"Ustekinumab; Medicine; Psoriasis; Double blind; Dermatology; Randomized controlled trial; Randomization; Internal medicine; Alternative medicine; Disease; Pathology; Placebo","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003160799,0.0007803337,0.001952045,0.0002426598,0.0003757456,0.0007873534,0.0005151061,0.001351078,0.003142102],"category_scores_gemma":[0.002168517,0.0003596619,0.001729851,0.0002840017,0.0007770427,0.0006682777,0.0002221684,0.002162229,0.0005548603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005339223,"about_ca_system_score_gemma":0.0008050216,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00046467,"about_ca_topic_score_gemma":0.0008927402,"domain_scores_codex":[0.9990786,0.0005930263,0.00007576156,0.00008764707,0.00008012623,0.00008482319],"domain_scores_gemma":[0.9982287,0.0007280401,0.0004659156,0.0001266733,0.0001131431,0.0003374819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9502728,0.007305604,0.003004664,0.00074117,0.001596745,0.000061591,0.00008989024,0.0003275973,0.004439862,0.00008848346,0.001179517,0.03089209],"study_design_scores_gemma":[0.9156024,0.0742235,0.007162232,0.00005644482,0.0008425055,0.0001128162,0.00002519931,0.0003739161,0.0007248407,0.00009677846,0.0007672595,0.00001205581],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898858,0.006503692,0.0003447315,0.0005488922,0.000136514,0.0008633466,0.0005084427,0.00004005721,0.00116845],"genre_scores_gemma":[0.9932633,0.002762438,0.0006528092,0.0007337051,0.0002478141,0.0007941309,0.000736397,0.00001461482,0.0007947882],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003160799,"threshold_uncertainty_score":0.01671612,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01798615141328034,"score_gpt":0.2754203383737347,"score_spread":0.2574341869604543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}